approved EB-1A

Postdoctoral Fellow

Medicinal Chemistry · Pakistan · 2025-02-07

Processing Time
90 days
Decision Date
2025-02-07
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Scholarly Articles (Met)

The petitioner authored 34 peer-reviewed journal articles and 2 book chapters in leading venues such as Cell Chemical Biology and Cancer Letters.

Judging (Met)

The petitioner conducted over 25 manuscript reviews for high-impact journals and served on editorial boards.

Original Contributions (Met)

The petitioner's work in structure-based drug design and CRISPR-based diagnostics resulted in 1,306 citations and evidence of compound commercialization.

Why This Petition Was Approved

The petition was approved based on meeting at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of others' work, and original scientific contributions of major significance. Specific metrics included 34 journal articles in high-impact venues like Cell Chemical Biology, 1,306 citations with an h-index of 17, and over 25 completed manuscript reviews. Evidence of the commercialization of key compounds further demonstrated the petitioner's extraordinary ability.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Conference Presentations
Judging Experience
Original Contributions
Commercial Success
Evidence Submitted
  • 34 peer-reviewed journal articles
  • 5 conference abstracts
  • 2 book chapters
  • 1,306 citations (top 1 percent of authors in field)
  • h-index of 17
  • Over 25 manuscript reviews for high-impact journals
  • Editorial board membership
  • Evidence of commercialization of key compounds
  • Ph.D. in medicinal chemistry

Similar Cases

Assistant Professor

Pharmaceuticals · India

WeGreened EB-1A rfe approved
Texas 558 days 2025-09-08
The approval was based on a significant publication record of 28 journal articles and a citation count exceeding 360, placing the petitioner in the top 1% of his field. Additionally, his 25 peer reviews and original contributions to antimicrobial and antidiabetic agents satisfied the EB-1A criteria.

Research Scientist

Research and Development · China

WeGreened EB-1A approved
Illinois 6 days 2024-11-05
The petition was approved based on the documentation of 24 peer-reviewed journal articles and a high citation count of 596, placing the applicant in the top 3% of her field. Additionally, her participation in at least 10 journal reviews satisfied the judging criterion. The case was further strengthened by evidence of support from the Department of Energy (DOE) and expert testimony regarding her impact on pharmaceutical development.

Postdoctoral Researcher

Pharmaceuticals · India

WeGreened EB-1A approved
North Carolina 18 days 2025-04-24
The petition was approved based on the authorship of 52 peer-reviewed journal articles and a massive citation count of 7,116, placing the petitioner in the top 1% of the field. Additionally, the petitioner demonstrated significant peer recognition through over 200 journal reviews and editorial board service. The evidence satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.

Professor

Chemicals · Egypt

WeGreened EB-1A approved
Saudi Arabia 12 days 2025-03-11
The petitioner demonstrated extraordinary ability through 306 peer-reviewed publications and 4,287 citations, placing him in the top 1% of researchers in his field. He satisfied the EB-1A criteria for judging the work of others with over 350 reviews and original contributions of major significance in catalysis and cancer therapeutics. The case was further supported by high-impact journal rankings and expert testimony regarding the work's global influence.

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 90 days
Criteria Met 3 / 3
Evidence Types 7

EB-1A Case Data

Scraped Case Data

Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist